Search research articles
Contact Us
Filters
Showing results (51-60 of 54) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 54 results.
Wiley Interdisciplinary Reviews. Climate Change
|
September 27, 2016
Community-based adaptation research in the Canadian Arctic
James D Ford, Ellie Stephenson, Ashlee Cunsolo Willox, et al.
The Clinical Journal of Pain
|
July 27, 2013
The Canadian STOP-PAIN project: the burden of chronic pain-does sex really matter?
Mélanie Racine, Dominique Dion, Gilles Dupuis, et al.
Metabolism: Clinical and Experimental
|
May 14, 2016
Effects of the BET-inhibitor, RVX-208 on the HDL lipidome and glucose metabolism in individuals with prediabetes: A randomized controlled trial
Andrew L Siebel, Si Khiang Trinh, Melissa F Formosa, et al.
Lancet (London, England)
|
June 24, 2026
Safety, pharmacokinetics, and exploratory efficacy of the oral ghrelin receptor agonist AC01 in heart failure with reduced ejection fraction (GOAL-HF1): a randomised, double-blind, placebo-controlled, phase 1b/2a study
Lars H Lund, Arantxa Barandiarán Aizpurua, Entela Bollano, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 54) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 54 results.
Wiley Interdisciplinary Reviews. Climate Change
|
September 27, 2016
Community-based adaptation research in the Canadian Arctic
James D Ford, Ellie Stephenson, Ashlee Cunsolo Willox, et al.
The Clinical Journal of Pain
|
July 27, 2013
The Canadian STOP-PAIN project: the burden of chronic pain-does sex really matter?
Mélanie Racine, Dominique Dion, Gilles Dupuis, et al.
Metabolism: Clinical and Experimental
|
May 14, 2016
Effects of the BET-inhibitor, RVX-208 on the HDL lipidome and glucose metabolism in individuals with prediabetes: A randomized controlled trial
Andrew L Siebel, Si Khiang Trinh, Melissa F Formosa, et al.
Lancet (London, England)
|
June 24, 2026
Safety, pharmacokinetics, and exploratory efficacy of the oral ghrelin receptor agonist AC01 in heart failure with reduced ejection fraction (GOAL-HF1): a randomised, double-blind, placebo-controlled, phase 1b/2a study
Lars H Lund, Arantxa Barandiarán Aizpurua, Entela Bollano, et al.
Page
of 6